Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results.
Saved in:
| Title: | Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results. |
|---|---|
| Authors: | Pal, Sumanta K.1 (AUTHOR) spal@coh.org, Bajorin, Dean2,3 (AUTHOR), Dizman, Nazli1 (AUTHOR), Hoffman‐Censits, Jean4 (AUTHOR), Quinn, David I.5 (AUTHOR), Petrylak, Daniel P.6 (AUTHOR), Galsky, Matthew D.7 (AUTHOR), Vaishampayan, Ulka8 (AUTHOR), De Giorgi, Ugo9 (AUTHOR), Gupta, Sumati10 (AUTHOR), Burris, Howard A.11 (AUTHOR), Soifer, Harris S.12 (AUTHOR), Li, Gary12 (AUTHOR), Wang, Hao13 (AUTHOR), Dambkowski, Carl L.14 (AUTHOR), Moran, Susan15 (AUTHOR), Daneshmand, Siamak16 (AUTHOR), Rosenberg, Jonathan E.17 (AUTHOR), Hoffman-Censits, Jean18 (AUTHOR) |
| Source: | Cancer (0008543X). Jun2020, Vol. 126 Issue 11, p2597-2606. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
